No Data
No Data
Why is the core product entering the harvest period, medical heart (02291) experiencing a high increase in performance but encountering a 'cooling off'?
On the B-side of the core product's volume increase, the company's development seems to have some "hidden worries".
Sinotai Medical [02291] is now trading at HKD 17.2, with a rise of 11.11%.
As of 15:58, Xin Tai Medical [02291] reported a price of HK$17.2, up HK$1.72 or 11.11% from the previous closing price of HK$15.48. The turnover was HK$2.3525 million, with a highest price of HK$17.2 and a lowest price of HK$14.98 today. Based on the closing price yesterday, the 10-day average price was HK$20.20, and the 50-day average price was HK$24.05. The current P/E ratio is 38.16 times, and the 14-day relative strength index is 1.03.
Sansure Medical (02291) fell by 16.90% to HKD 15.280, hitting a 52-week low.
As of 11:46, Heart Medical (02291) fell by 16.90% compared to the previous closing price, now trading at 15.280 yuan, hitting a 52-week low; volume of 0.055 million shares, turnover of 0.8405 million Hong Kong dollars.
Did the aftermath of Lepu Medical Technology's (300003.SZ) "merger and acquisition for growth" strategy show up, with declining performance and high goodwill?
The development risks of "merger maniac" lepu medical technology seem to be emerging.
Are Poor Financial Prospects Dragging Down LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291 Stock?
LEPU ScienTech Medical Technology's Profit Leaps 86% in H1
No Data
No Data